Reading this on a mobile device? Try our optimized mobile version here:

January 4, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  • Study: Alcohol-impregnated disinfection cap may lower infection rates
    Researchers looked at contamination rates among 799 patients from three U.S. hospitals and found a 52% decline in the incidence of central line-associated bloodstream infections when a 70% alcohol-impregnated disinfection cap was used, instead of a standard cleaning protocol. Systemwide use of alcohol-impregnated disinfection caps would prevent 21 CLABSIs and four deaths annually, researchers estimated. The study appeared in the American Journal of Infection Control. (1/3) LinkedInFacebookTwitterEmail this Story
Announcing the Arrival of FMH RapidScreen from Immucor
The new FMH RapidScreen offers a faster more simplified feto-maternal hemorrhage screening test to give you peace of mind in generating a quick result for the protection of mothers and their newborns. FMH RapidScreen provides up to 35% decrease in total test time compared to other marketed tests. To learn more about this product, call us at 855-IMMUCOR or visit our website.

  Science & Health 
  • Researchers rejuvenate mature immune cells
    Japanese researchers turned mature immune T-cells into T-cells that replicated more, had longer lifespans and were better able to target diseased cells, according to two studies published in the journal Cell Stem Cell. Researchers converted T-cells from a patient with HIV into pluripotent stem cells in one of the studies. In the other, researchers started with T-cells from a patient with melanoma. Researchers in both studies were able to turn the pluripotent stem cells back into T-cells. "The next step we are going to do is examine whether these regenerated T-cells can selectively kill tumor cells but not other healthy tissues," lead author Dr. Hiroshi Kawamoto said. HealthDay News (1/3) LinkedInFacebookTwitterEmail this Story
  • High-dose flu vaccine may improve seroprotection in HIV patients
    Researchers studied 190 HIV patients and found that those who received four times the standard dose of influenza vaccine showed greater seroprotection against the flu than those who received normal doses. "For every antigen studied, the high-dose formulation resulted in an increased average antibody titer and higher seroconversion and seroprotective rates compared with the standard-dose influenza vaccine," according to the study in Annals of Internal Medicine. MedPage Today (free registration) (1/2) LinkedInFacebookTwitterEmail this Story
  • Studies explore agents for treatment of hepatitis C
    Experimental treatments for the hepatitis C virus could eliminate the need for interferon therapy in previously untreated patients, according to two studies published in the New England Journal of Medicine. In one study, the nucleotide polymerase inhibitor sofosbuvir and ribavirin were administered for up to 12 weeks and appeared effective at treating patients regardless of virus genotype as long as they had not previously taken interferon and ribavirin. In the second study, researchers found that a combination of ABT-450, ABT-333 and ribavirin yielded promising results for patients with genotype 1 virus who had not been previously treated. The findings may help advance the development of an interferon-free, all-oral treatment protocol, researchers said. MedPage Today (free registration) (1/2) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Meaningful use, ACOs among key trends for health IT this year
    The health IT industry is expected to strengthen its focus on patient involvement this year as a result of the Affordable Care Act. The new year also will see a greater emphasis on data analytics and interpretation, more provider groups in accountable care organizations and tougher, more complex meaningful use requirements, according to this article. Government Health IT online (12/31) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  Government & Regulatory 
  • Obama signs "fiscal cliff" bill delaying SGR fee cuts
    President Barack Obama on Wednesday signed the American Taxpayer Relief Act of 2012, popularly known as the "fiscal cliff" legislation. The measure delays for one year an almost 27% cut in doctor fees under the Medicare sustainable growth rate formula. The bill, however, compensates for the SGR fix with budget cuts in other areas, including $800 million in fee cuts in radiology and $300 million in cuts in radiation oncology. (free registration) (1/3) LinkedInFacebookTwitterEmail this Story
  • Agency asks for feedback on ICD-10 testing program
    CMS is developing an ICD-10 testing program and is asking for provider feedback via listening sessions. The Healthcare Billing and Management Association was tasked with defining the key concepts for ICD-10 preparedness and compliance. (1/3) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Transfusion News video explores progress in treatment for thrombotic thrombocytopenic purpura
    A video posted on the Transfusion News website describes the use of immunomodulation therapy to help manage thrombotic thrombocytopenic purpura, or TTP, which is a rare but serious blood disorder that can cause catastrophic damage if not quickly diagnosed and treated. The video points out that earlier administration of rituximab, often with corticosteroids, may result in better patient outcomes. Progress in the treatment of TTP is discussed in an editorial and two reports appearing in the December issue of "Transfusion." Transfusion News is produced through a partnership between Ortho Clinical Diagnostics and AABB. The site features videos, articles, breaking news and commentary from transfusion and cellular therapy experts. Transfusion News may be accessed through the website for the journal "Transfusion," under "Special Features," or directly at LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Director of Quality SystemsRock River Valley Blood CenterUS - IL - Rockford
LABORATORY MANAGERUnited Blood ServicesUS - NV - Las Vegas
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
Click here to view more job listings.

Beware the fury of a patient man."
--John Dryden,
British poet, critic and playwright

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information